<scp>FBXL16</scp> promotes cell growth and drug resistance in lung adenocarcinomas with <i>KRAS</i> mutation by stabilizing <scp>IRS1</scp> and upregulating <scp>IRS1</scp>/<scp>AKT</scp> signaling
Marion Morel(Wright State University), Weiwen Long(Wright State University)
Cited by 8
Related Papers
ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion
|Journal of Clinical Investigation|2012|168
ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis
|Cell Reports|2015|93
Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness
|Journal of Biological Chemistry|2018|44
Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3
|Cell Reports|2018|40
Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis
|International Journal for Parasitology Drugs and Drug Resistance|2014|39